Verona Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Verona Pharma and buy or sell other stocks, ETFs, and their options commission-free!

About VRNA

Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. 

CEO
Benjamin Lucas
CEOBenjamin Lucas
Employees
209
Employees209
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2005
Founded2005
Employees
209
Employees209

VRNA Key Statistics

Market cap
9.19B
Market cap9.19B
Price-Earnings ratio
-103.78
Price-Earnings ratio-103.78
Dividend yield
—
Dividend yield—
Average volume
384.22K
Average volume384.22K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$106.93
52 Week high$106.93
52 Week low
$31.60
52 Week low$31.60

VRNA News

TipRanks 7d
M&A News: Revolution Medicines Stock Rallies on News of Potential Acquisition by Merck

Shares of biotech Revolution Medicines (RVMD) rallied more than 13% in Friday’s pre-market trading, after rising 4.6% yesterday in reaction to news of a potenti...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .